BR9607679B8 - Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica. - Google Patents

Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica.

Info

Publication number
BR9607679B8
BR9607679B8 BRPI9607679-8B8D BR9607679D BR9607679B8 BR 9607679 B8 BR9607679 B8 BR 9607679B8 BR 9607679 D BR9607679 D BR 9607679D BR 9607679 B8 BR9607679 B8 BR 9607679B8
Authority
BR
Brazil
Prior art keywords
gastrite
dysppsy
bicarbornate
potassium
pharmaceutical composition
Prior art date
Application number
BRPI9607679-8B8D
Other languages
English (en)
Inventor
Paul Frederick Field
Original Assignee
Reckitt Benckiser Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770811&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9607679(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare Ltd filed Critical Reckitt Benckiser Healthcare Ltd
Publication of BR9607679B8 publication Critical patent/BR9607679B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI9607679-8B8D 1995-03-03 1996-02-16 Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica. BR9607679B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions

Publications (1)

Publication Number Publication Date
BR9607679B8 true BR9607679B8 (pt) 2014-11-18

Family

ID=10770811

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9607679A BR9607679A (pt) 1995-03-03 1996-02-16 Uso de bicarbonato de potássio composição farmacêutica e processo para tratar esofagite de refluxo gastrite dispepsia ou ulceração péptica
BRPI9607679-8B8D BR9607679B8 (pt) 1995-03-03 1996-02-16 Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9607679A BR9607679A (pt) 1995-03-03 1996-02-16 Uso de bicarbonato de potássio composição farmacêutica e processo para tratar esofagite de refluxo gastrite dispepsia ou ulceração péptica

Country Status (22)

Country Link
US (1) US5681827A (pt)
EP (1) EP0813407B1 (pt)
JP (1) JPH11501044A (pt)
KR (1) KR19980702689A (pt)
CN (1) CN1123337C (pt)
AR (1) AR004168A1 (pt)
AT (1) ATE218853T1 (pt)
AU (1) AU696480B2 (pt)
BR (2) BR9607679A (pt)
CZ (1) CZ289386B6 (pt)
DE (1) DE69621785T2 (pt)
ES (1) ES2174054T3 (pt)
GB (1) GB9504599D0 (pt)
HK (1) HK1007957A1 (pt)
HU (1) HUP9801414A3 (pt)
NO (1) NO316207B1 (pt)
NZ (1) NZ301749A (pt)
PL (1) PL184245B1 (pt)
PT (1) PT813407E (pt)
TR (1) TR199700891T1 (pt)
WO (1) WO1996027368A1 (pt)
ZA (1) ZA961517B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
CN1286468C (zh) * 1997-04-30 2006-11-29 雷克特本克斯尔保健(英国)有限公司 含藻酸或藻酸盐的药物组合物
US6027715A (en) * 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP3959192B2 (ja) * 1998-12-03 2007-08-15 株式会社大塚製薬工場 経管栄養食品
US6351665B1 (en) 1999-05-07 2002-02-26 Kenneth L Koch Method and apparatus for evaluating myoelectric signals and identifying artifact
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
AU2006340298B2 (en) * 2006-03-16 2012-10-04 Glycologic Limited Gastric raft composition comprising preferably processed starches for inducing satiety
KR20090115936A (ko) 2007-02-13 2009-11-10 에스-바이오텍 홀딩 에이피에스 알긴산을 포함한 식이요법 제품
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
KR100930809B1 (ko) * 2008-02-13 2009-12-09 (주)포테이토밸리 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
KR20120108218A (ko) * 2011-03-23 2012-10-05 동아제약주식회사 위식도 역류질환 치료용 액상 타입 조성물
EP2767286B1 (de) * 2011-10-14 2018-01-17 Obshestvo S Ogranichennoj Otvetstvennostju "CytoNIR" Orale pharmazeutische zusammensetzung zur behandlung von entzündlichen magen-darm-erkrankungen
WO2013111077A1 (en) * 2012-01-27 2013-08-01 Institute Of Bioorganic Chemistry Pharmaceutical composition as a substance for antireflux antacid drug
US9636360B2 (en) * 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
DE3586281T2 (de) * 1984-04-19 1992-12-10 Rhone Poulenc Rorer Int Antisaeurezusammensetzung.
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
NO973964L (no) 1997-08-28
BR9607679A (pt) 1998-07-07
AU4724496A (en) 1996-09-23
ES2174054T3 (es) 2002-11-01
TR199700891T1 (xx) 1998-02-21
AR004168A1 (es) 1998-11-04
NZ301749A (en) 1998-05-27
CZ289386B6 (cs) 2002-01-16
AU696480B2 (en) 1998-09-10
CN1123337C (zh) 2003-10-08
NO316207B1 (no) 2003-12-29
HUP9801414A2 (hu) 1999-01-28
ATE218853T1 (de) 2002-06-15
DE69621785D1 (de) 2002-07-18
NO973964D0 (no) 1997-08-28
WO1996027368A1 (en) 1996-09-12
US5681827A (en) 1997-10-28
PL184245B1 (pl) 2002-09-30
EP0813407A1 (en) 1997-12-29
GB9504599D0 (en) 1995-04-26
ZA961517B (en) 1996-09-03
MX9706661A (es) 1997-11-29
PL322044A1 (en) 1998-01-05
HK1007957A1 (en) 1999-04-30
KR19980702689A (ko) 1998-08-05
CN1177292A (zh) 1998-03-25
PT813407E (pt) 2002-10-31
EP0813407B1 (en) 2002-06-12
JPH11501044A (ja) 1999-01-26
HUP9801414A3 (en) 2001-04-28
CZ274997A3 (cs) 1998-03-18
DE69621785T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
BR9607679B8 (pt) Uso de bicarbornato de potássio, composição farmacêutica, e, processo para tratar esofagite de refluxo, gastrite, dispepsia ou ulceração péptica.
BR9810116B1 (pt) composição de solução e processo para sua preparação.
BR9603431A (pt) Método para tratar privação de abuso de substância
DK0751129T3 (da) Substituerede dihydrodibenz/b,f/azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle li
BR9403442A (pt) Silanos, processo para sua produção e aplicação dos ditos silanos
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
BR9100438A (pt) Derivados de halogenoalil azolita,processo para sua preparacao,composicoes microbicidas,aplicacao,processos para combater microorganismos e para a preparacao de composicoes
BR9815047B1 (pt) composição de aditivo para borracha, processo para sua preparação e sua aplicação.
PT712860E (pt) Processo para purificacao e isolamento de 2'-deoxi-2', 2'-difluoronucleosidos
BR9002939A (pt) Derivado de n-fenil-pirazol,processo para prepara-lo,composicao pesticida e metodo para combater pragas de artopodes,nematoides,helmintas ou protozoarios
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
BR9610375A (pt) Extrato de células composição cosmética ou farmacêutica utilização de pelo menos um extrato de células e processo de tratamento cosmético
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
MX9202159A (es) Metodo para identificar usuario de cupones.
DE69019229D1 (de) Ozonspaltung.
BR9006252A (pt) Microemulsoes concentradas,processo de preparacao destas microemulsoes e sua utilizacao
BR9713977B1 (pt) composto análogo de comptotecina, e, utilização e processo para preparação do mesmo.
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
BR9807227B1 (pt) composiÇço herbicida para tratamento foliar, processo de eliminaÇço e uso de referida composiÇço herbicida.
BR8803768A (pt) Composicao odorante,processo para producao de compostos e uso dos ditos compostos
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
BR9509925A (pt) Composição e uso da composição para prevenção ou tratamento de infecção por hiv-1